Jeremy Bender - CHIEF EXECUTIVE OFFICER, Director at Day One Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Issuer Symbol
DAWN on Nasdaq
All Insider Reports
All Insider Reports

Jeremy Bender - trading volume in the past year for Day One Biopharmaceuticals, Inc.

Holdings reported by Jeremy Bender for Day One Biopharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 300,000 $3,534,000 $11.78 15 Feb 2026 Indirect
Restricted Stock Units 237,000 $2,489,213 $13.31 30 Jan 2026 Direct Common Stock
Common Stock 204,603 $2,373,578 $11.60 17 Feb 2026 Direct
Restricted Stock Unit (RSU) 222,188 $2,097,269 $11.96 15 Feb 2026 Direct Common Stock
Stock Option (right to buy Common Stock) 355,000 30 Jan 2026 Direct Common Stock

Transactions reported by Jeremy Bender for Day One Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.